AETHON Trademark

Trademark Overview


On Thursday, May 30, 2024, a trademark application was filed for AETHON with the United States Patent and Trademark Office. The USPTO has given the AETHON trademark a serial number of 98575759. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 21, 2025. This trademark is owned by AETHON THERAPEUTICS, INC.. The AETHON trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antibodies for medical purposes; antibody reagents used for the therapeutic targeting of antigens in cells and tissue for medical purposes; pharmaceutical products for the treatment of cancer

Scientific research in the field of pharmaceuticals; research and development services in the field of antibodies; medical research services in the field of cancer
aethon

General Information


Serial Number98575759
Word MarkAETHON
Filing DateThursday, May 30, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 21, 2025

Trademark Statements


Description of MarkThe mark consists of the word AETHON in stylized lowercase letters; an asterisk behind the initial letter "a".
Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antibodies for medical purposes; antibody reagents used for the therapeutic targeting of antigens in cells and tissue for medical purposes; pharmaceutical products for the treatment of cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScientific research in the field of pharmaceuticals; research and development services in the field of antibodies; medical research services in the field of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 30, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAETHON THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10169

Party NameAETHON THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10169

Trademark Events


Event DateEvent Description
Thursday, May 30, 2024NEW APPLICATION ENTERED
Tuesday, October 15, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, October 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 12, 2024ASSIGNED TO EXAMINER
Saturday, December 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 15, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 21, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED